Extracellular matrix and dermal fibroblasts

The extracellular matrix (ECM) and dermal fibroblasts represent a complex functional unit essential for skin integrity and repair. Dermal fibroblasts are the primary cellular components of the dermis, responsible for the synthesis, assembly, and maintenance of ECM components, including collagen, elastin, and glycosaminoglycans (PubMed: 30126121). The ECM, in turn, provides the structural scaffold and biochemical cues that regulate fibroblast behavior, such as proliferation, migration, and differentiation into myofibroblasts (PubMed: 24535019). This reciprocal interaction is critical for normal wound healing but becomes dysregulated in pathological conditions like skin aging, where ECM degradation exceeds synthesis, or fibrosis, where excessive ECM deposition leads to organ dysfunction (StatPearls: Skin Anatomy). Therapeutic interventions often target this relationship by using retinoids to stimulate collagen production or TGF-beta inhibitors to prevent pathological fibroblast activation in fibrotic diseases (PubMed: 28254089).

Other names

Dermal extracellular matrixFibroblast-ECM nicheSkin connective tissueDermal stroma

Drugs targeting this system typically act by modulating fibroblast activation, stimulating the synthesis of structural proteins like collagen and elastin, or inhibiting matrix-degrading enzymes such as matrix metalloproteinases (MMPs).